Investor hopes for two experimental Alzheimer’s treatments have grown even fainter after Pfizer Inc said its treatment failed in one of four big clinical trials.

Pfizer and Eli Lilly and Co are due to present key data on their drugs, which target the same protein, in the next two months. Expectations that either medicine…